News & Events

Biochemist Erich Wanker studies neurodegenerative diseases such as Parkinson’s and Huntington’s disease. When we asked him for a reading recommendation, he was enthusiastic: He chose a dystopic novel from the 1950s, which later served as the basis for a film by François Truffaut.

From November 1 to 10, 2024, researchers and science enthusiasts will come together during Berlin Science Week to discuss important questions about science and society. Kicking off the week, the Max Delbrück Center will present its photo exhibition “Discoverers” for the first time.

Cancer treatment has become complex. An AI based online tool developed by researchers at the Max Delbrück Center can already help oncologists and cancer patients find the most up to date personalized treatment.

What opportunities lie ahead for the future of medical research and healthcare? Scientists from the Helmholtz Association share their ideas with decision-makers from science, politics, patient organizations, biotech, and the pharmaceutical industry at the first Helmholtz Health Summit in Berlin.

We at the Helmholtz Association have everything we need to leverage the potential of biomedical engineering in Germany. We simply need to assemble all the puzzle pieces thoughtfully and unite people who have never collaborated before, says our Scientific Director Maike Sander.

In mid-September, researchers from all over the world gathered in Berlin to explore the current and future possibilities of magnetic resonance imaging. The annual symposium was hosted by the team of physicist Professor Thoralf Niendorf from the Max Delbrück Center.

Ashley Sanders, Group Leader of the Genome Instability and Somatic Mosaicism Lab, developed a technique to sequence strands of DNA in single cells. Today it is the most accurate method to detect DNA rearrangements. She hopes the technique will help reveal clues on how diseases develop.

Enno Klußmann of the Max Delbrück Center aims to help reducing the harmful consequences of high blood pressure by imitating a rare mutation. His plan to activate a specific enzyme called PDE3A to protect the heart and kidneys is now being funded with €400,000 by the Else Kröner-Fresenius Foundation.

From November 1 to 10, 2024, researchers and science enthusiasts will once again gather in Berlin to discuss current developments and challenges in science, business and society - with each other and with the public. The Max Delbrück Center will once again be contributing exciting events this year, online and on site. Join us!